Empar Management

Empar Management appears to be a small management or financial consulting business associated with James T. Parsons rather than a drug developer, pharmaceutical company, or healthcare operating company. Public references to the entity are limited and primarily come from executive biographies stating that Parsons served as President of Empar Management before joining Trillium Therapeutics. There is no clear evidence that Empar Management has its own therapeutic pipeline, R&D platform, clinical programs, marketed products, or healthcare services business. Based on currently available public information, it is best characterized as a private consulting entity and not a life sciences company.